FI103668B1 - Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi - Google Patents

Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi

Info

Publication number
FI103668B1
FI103668B1 FI911193A FI911193A FI103668B1 FI 103668 B1 FI103668 B1 FI 103668B1 FI 911193 A FI911193 A FI 911193A FI 911193 A FI911193 A FI 911193A FI 103668 B1 FI103668 B1 FI 103668B1
Authority
FI
Finland
Prior art keywords
pct
unidimers
indole
preparation
pharmacologically active
Prior art date
Application number
FI911193A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI103668B (fi
FI911193A0 (fi
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI911193A0 publication Critical patent/FI911193A0/fi
Application granted granted Critical
Publication of FI103668B publication Critical patent/FI103668B/fi
Publication of FI103668B1 publication Critical patent/FI103668B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Artificial Filaments (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Television Receiver Circuits (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Stereophonic System (AREA)
  • Television Systems (AREA)
FI911193A 1988-09-12 1991-03-11 Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi FI103668B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
US24335088 1988-09-12
US8903329 1989-08-07
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (3)

Publication Number Publication Date
FI911193A0 FI911193A0 (fi) 1991-03-11
FI103668B FI103668B (fi) 1999-08-13
FI103668B1 true FI103668B1 (fi) 1999-08-13

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911193A FI103668B1 (fi) 1988-09-12 1991-03-11 Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi

Country Status (14)

Country Link
US (1) US5541339A (cs)
JP (1) JP3380237B2 (cs)
KR (1) KR0137959B1 (cs)
AT (1) ATE198335T1 (cs)
AU (1) AU632288B2 (cs)
CA (1) CA1340215C (cs)
DE (1) DE68929275T2 (cs)
DK (1) DK175458B1 (cs)
FI (1) FI103668B1 (cs)
GR (1) GR3035589T3 (cs)
LV (1) LV12806B (cs)
NO (1) NO303498B1 (cs)
TW (1) TW217383B (cs)
WO (1) WO1990002746A1 (cs)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0563475T3 (da) * 1992-03-25 2000-09-18 Immunogen Inc Konjugater af cellebindende midler og derivater af CC-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
EP2163256B1 (en) 2001-05-11 2015-09-02 Ludwig Institute for Cancer Research Ltd. Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
YU37904A (sh) 2001-11-09 2006-08-17 Boehringer Ingelheim Pharmaceuticals Inc. Benzimidazoli kao korisni inhibitori proteinske kinaze
JP2005536533A (ja) * 2002-08-08 2005-12-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 置換ベンゾイミダゾール化合物
JP2006505571A (ja) * 2002-10-15 2006-02-16 リゲル ファーマシューテイカルズ、インコーポレイテッド 置換されたインドール及びｈｃｖ阻害剤としてのその使用
JP4750701B2 (ja) * 2003-07-07 2011-08-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング マロンアミド誘導体
WO2005079791A1 (en) * 2004-02-12 2005-09-01 Boehringer Ingelheim Pharmaceuticals, Inc. Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
CN101287728A (zh) * 2005-08-17 2008-10-15 先灵公司 新的高亲和力噻吩基和呋喃基激酶配体
JP5276017B2 (ja) 2007-01-25 2013-08-28 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｅｇｆｒ変異体仲介性疾患の治療における抗ｅｇｆｒ抗体の使用
US9023356B2 (en) 2007-03-15 2015-05-05 Ludwig Institute For Cancer Research Ltd Treatment method using EGFR antibodies and SRC inhibitors and related formulations
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
US9283276B2 (en) 2007-08-14 2016-03-15 Ludwig Institute For Cancer Research Ltd. Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
NO2344478T3 (cs) 2008-11-03 2018-02-24
DK2560645T3 (en) 2010-04-21 2016-10-10 Syntarga Bv Conjugates of CC-1065 analogs and bifunctional linking groups
EP2908809A2 (en) 2012-10-22 2015-08-26 Arnold Glazier Methods for the effective treatment of metastatic cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
DK3092010T3 (en) 2014-01-10 2018-08-27 Synthon Biopharmaceuticals Bv Process for purification of Cys-linked antibody-drug conjugates
SI3099692T1 (sl) * 2014-01-27 2019-06-28 Pfizer Inc. Bifunkcionalna citotoksična zdravila
EP3682904A1 (en) 2014-06-30 2020-07-22 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
TWI712605B (zh) * 2015-03-20 2020-12-11 美商輝瑞股份有限公司 含有ｃｔｉ藥效基團之雙功能性細胞毒性劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
ATE112279T1 (de) * 1986-12-19 1994-10-15 Upjohn Co Cc-1065 analoge.

Also Published As

Publication number Publication date
DK41791A (da) 1991-03-08
FI103668B (fi) 1999-08-13
JP3380237B2 (ja) 2003-02-24
DE68929275D1 (de) 2001-02-01
ATE198335T1 (de) 2001-01-15
FI911193A0 (fi) 1991-03-11
CA1340215C (en) 1998-12-15
DE68929275T2 (de) 2001-05-23
TW217383B (cs) 1993-12-11
LV12806B (lv) 2002-05-20
NO910958D0 (no) 1991-03-11
US5541339A (en) 1996-07-30
NO303498B1 (no) 1998-07-20
GR3035589T3 (en) 2001-06-29
AU4192289A (en) 1990-04-02
KR0137959B1 (ko) 1998-05-15
KR900701801A (ko) 1990-12-04
JPH04500664A (ja) 1992-02-06
WO1990002746A1 (en) 1990-03-22
LV12806A (en) 2002-03-20
NO910958L (no) 1991-05-10
DK175458B1 (da) 2004-11-01
DK41791D0 (da) 1991-03-08
AU632288B2 (en) 1992-12-24

Similar Documents

Publication Publication Date Title
FI103668B1 (fi) Menetelmä farmakologisesti aktiivisten pyrrolo[3,2-e]indol-4(5H)-onidimeerien valmistamiseksi
TR200000197T2 (tr) Yeni bileşimler
KR960009264B1 (en) Novel cc-1065 analogs
TR200000151T2 (tr) Yeni bileşimler.
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
WO1992007830A3 (en) Oxindole peptide antagonists
NO20000313L (no) Nye forbindelser
SE9702564D0 (sv) New compounds
BR9907934A (pt) Composto, composição farmacêutica, e, processo para a preparação do composto
ES2037670T3 (es) Procedimiento para la preparacion de complejos de (2,2-bis(aminometil)-1,3-propanodiol-n,n') platino.
SE9802574D0 (sv) Novel compounds
FI875501A0 (fi) 6,7-dihydro-/1,2,4/triazolo/1,5-a// 1,3,5/triazin-2-sulfonsyraamider, foerfarande foer deras framstaellning och deras anvaendning som medel med herbicid och vaextreglerande verkan.
NZ208996A (en) 5-substituted(1,2,4 triazpyrimidin-2-amine derivatives and pharmaceutical compositions
BE898856A (fr) Analogues de mitomycine
DE3782831D1 (de) (gem-heterocyclodimethanamin-n,n')platin komplexe.
ATE41003T1 (de) Tetrazolothienopyridine.
BR8108862A (pt) Hidroximidato e tiol-hidroximidatos heterobiciclicos e seus derivados ester -carbamato com atividade biologica

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY

MA Patent expired